Brokerages Set DocuSign, Inc. (NASDAQ:DOCU) Price Target at $92.45

Shares of DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) have been given a consensus rating of "Hold" by the thirteen research firms that are presently covering the firm, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. The average 12-month target price among brokers that have covered the stock in the last year is $92.45.

A number of research firms recently commented on DOCU. Wells Fargo & Company increased their target price on shares of DocuSign from $50.00 to $70.00 and gave the company an "underweight" rating in a research report on Friday, December 6th. Piper Sandler boosted their target price on DocuSign from $60.00 to $90.00 and gave the company a "neutral" rating in a report on Friday, December 6th. JMP Securities restated a "market outperform" rating and set a $124.00 price target on shares of DocuSign in a research note on Tuesday, January 7th. HSBC reiterated a "reduce" rating on shares of DocuSign in a research note on Friday, December 6th. Finally, Citigroup raised their target price on shares of DocuSign from $87.00 to $113.00 and gave the stock a "buy" rating in a research report on Friday, December 6th.

Insider Buying and Selling

In other DocuSign news, Director Daniel D. Springer sold 581,588 shares of the stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $97.04, for a total transaction of $56,437,299.52. Following the sale, the director now owns 906,430 shares in the company, valued at approximately $87,959,967.20. This represents a 39.08 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the business's stock in a transaction on Monday, December 16th. The stock was sold at an average price of $94.77, for a total value of $758,160.00. Following the completion of the transaction, the chief financial officer now directly owns 101,439 shares of the company's stock, valued at approximately $9,613,374.03. This trade represents a 7.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 686,010 shares of company stock worth $66,102,694 in the last three months. Corporate insiders own 1.66% of the company's stock.

Institutional Trading of DocuSign

A number of hedge funds have recently bought and sold shares of DOCU. Audent Global Asset Management LLC boosted its holdings in shares of DocuSign by 382.6% during the fourth quarter. Audent Global Asset Management LLC now owns 27,425 shares of the company's stock worth $2,467,000 after purchasing an additional 21,742 shares during the last quarter. Siemens Fonds Invest GmbH purchased a new position in DocuSign during the fourth quarter worth about $772,000. Fluent Financial LLC purchased a new position in DocuSign during the fourth quarter worth about $694,000. Total Wealth Planning & Management Inc. acquired a new stake in DocuSign in the 4th quarter worth about $312,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in DocuSign in the 4th quarter valued at about $14,463,000. Institutional investors and hedge funds own 77.64% of the company's stock.

DocuSign Price Performance

Shares of DOCU traded up $0.35 during mid-day trading on Friday, reaching $82.05. The company's stock had a trading volume of 1,258,612 shares, compared to its average volume of 2,012,093. The company's 50 day moving average is $90.14 and its 200 day moving average is $78.07. The stock has a market cap of $16.58 billion, a PE ratio of 16.92, a price-to-earnings-growth ratio of 6.94 and a beta of 0.89. DocuSign has a 12-month low of $48.70 and a 12-month high of $107.86.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.